Intrexon | XON - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Agenus USD 18.74M 16.26M 2026-06
Alaunos Therapeutics USD 124K 230K 2026-06
Amgen USD 13.19B 799M 2026-09
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Gilead Sciences USD 3.18B 4.45B 2026-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Incyte USD 3.85B 127.8M 2026-09
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Ligand Pharmaceuticals USD 55.96M 950.74M 2026-09
MacroGenics USD 113.91M 47.39M 2026-06
MannKind USD 41.28M 11.65M 2026-09
Merck USD 9.55B 2.7B 2026-09
Novartis USD 8.87B 1.25B 2026-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Thermo Fisher Scientific USD 5.46B 1.4B 2026-09
Veracyte USD 199.83M 99.69M 2026-09
Xencor USD 59.62M 14.96M 2026-09